Skip to content
TrialScanner

NCT04123574

A Pilot Study of BXCL701 in Patients With Pancreatic Cancer

Early Phase 1WithdrawnBTAIQLeadIQVCollaborator

Registry record

Lead sponsor
BioXcel Therapeutics Inc
Conditions
Cancer of Pancreas; Cancer of the Pancreas; Neoplasms, Pancreatic; Pancreas Cancer; Pancreatic Cancer
Primary completion
Dec 6, 2021Sponsor estimate
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Sponsor estimate: the sponsor registered this date in advance and can move it. A primary completion date is when the last participant is measured, not when results are announced.

Open NCT04123574 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04123574: A Pilot Study of BXCL701 in... | TrialScanner